New Patient Enrollment
Receive a free starter vial of Vetsulin® for newly diagnosed pets!
Dear veterinary professional,
Thank you for your continued loyalty! As a show of appreciation and support, we’re offering registered participants of this exclusive program the opportunity to provide a free starter vial of Vetsulin to patients newly diagnosed with pet diabetes.
Just follow the steps below:
Provide a vial of Vetsulin from your stock to the pet parent at the time of diagnosis.
Enter your patient’s information in the adjacent form.
Receive a replacement vial from Merck Animal Health within 6 weeks.
Bookmark this page to enroll your newly diagnosed diabetic patients.
Not a member of the program?
Contact your Merck Animal Health Representative for more information.
The Newly Diagnosed Pet Enrollment for 2024 has ended
Vetsulin Professional Resources
Take advantage of patient and practice resources, such as the Customized Discharge Forms. These easy-to-use forms help you provide clients with clear instructions for Vetsulin dosing and information.
Terms and conditions:
The program applies only to pets newly diagnosed with diabetes mellitus and is limited to select Vetsulin customers. Clinics should supply a vial from their inventory to the pet parent. Merck Animal Health will ship a replacement vial to your clinic. Customers should allow up to 6 weeks for product delivery.
Privacy Policy:
Information submitted is subject to the Privacy Policy stated on the Company’s Website. To read the Privacy Policy, visit: https://msdprivacy.com/us/en/index.html
Important Safety Information:
VETSULIN® and VETPEN® are for use in animals only. Dogs and cats known to have an allergy to pork or pork products should not be treated with VETSULIN®. VETSULIN® is contraindicated during periods of hypoglycemia. Animals with severe ketoacidosis, anorexia, lethargy, and/or vomiting should be stabilized with short-acting insulin and appropriate supportive therapy before use. As with all insulin products, careful patient monitoring for hypoglycemia and hyperglycemia is essential. Overdosage can result in profound hypoglycemia and death. Progestogen and glucocorticoid use should be avoided. The safety and effectiveness of VETSULIN® in puppies, kittens, breeding, pregnant, and lactating dogs and cats has not been evaluated. Keep out of reach of children. Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for at least 15 minutes. Accidental injection may cause clinical hypoglycemia. In case of accidental injection, seek medical attention immediately. Exposure to the product may induce a local or systemic allergic reaction in sensitized individuals. For complete safety information, refer to the product label.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global